a year ago
FATE
AnalystsRobert BurnsRobert Burns's Stock Forecasts
AnalystsRobert Burns
Sectors:
Industries:
Analyst Ranking
Bottom 1%
#4555 out of 4563 analysts
Average Return
-12.7%
Win Rate
28%81 out of 294
Risk vs Reward
Poor
Good
Robert Burns's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Adc Therapeutics SaADCT | +573.24% | $0.71 | $4.78 | 2023-11-20 - 2024-04-24 | Buy |
Adc Therapeutics SaADCT | +497.50% | $0.80 | $4.78 | 2023-09-19 - 2024-04-24 | Buy |
Immunomedics IncIMMU | +342.36% | $18.91 | $83.65 | 2020-04-07 - 2020-09-14 | Buy |
Adc Therapeutics SaADCT | +270.54% | $1.29 | $4.78 | 2023-07-25 - 2024-04-24 | Buy |
Turning Point Therapeutics IncTPTX | +208.74% | $35.13 | $108.46 | 2020-03-17 - 2021-03-17 | Buy |
Robert Burns Analyst Color
Get additional color on Robert Burns's coverage of popular stocks
Robert Burns's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Igm Biosciences IncIGMS | 11 | Hold | $12.00 | +50.75% | Reiterates | 7 days ago |
Biontech SeBNTX | 21 | Buy | $107.00 | +21.47% | Reiterates | 8 days ago |
Viracta Therapeutics IncVIRX | 8 | Buy | $4.00 | +378.47% | Reiterates | 9 days ago |
Adc Therapeutics SaADCT | 14 | Buy | $9.00 | +88.28% | Reiterates | 10 days ago |
Apollomics IncAPLM | 4 | Buy | $5.00 | +986.96% | Maintains | 24 days ago |
Nuvation Bio IncNUVB | 7 | Buy | $8.00 | +200.75% | Maintains | a month ago |
Effector Therapeutics IncEFTR | 3 | Buy | $24.00 | +1,197.30% | Reiterates | a month ago |
Calidi Biotherapeutics IncCLDI | 2 | Buy | $2.00 | +1,165.82% | Maintains | a month ago |
Oric Pharmaceuticals IncORIC | 13 | Buy | $21.00 | +159.90% | Maintains | a month ago |
Tango Therapeutics IncTNGX | 5 | Buy | $17.00 | +119.07% | Maintains | a month ago |
Allogene Therapeutics IncALLO | 9 | Buy | $10.00 | +228.95% | Reiterates | a month ago |
Caribou Biosciences IncCRBU | 6 | Buy | $24.00 | +523.38% | Maintains | a month ago |
Black Diamond Therapeutics IncBDTX | 5 | Buy | $12.00 | +137.15% | Reiterates | a month ago |
Macrogenics IncMGNX | 12 | Hold | $16.00 | +1.91% | Maintains | a month ago |
Zymeworks IncZYME | 12 | Hold | $10.00 | +16.96% | Maintains | a month ago |
Revolution Medicines IncRVMD | 11 | Buy | $44.00 | +23.63% | Maintains | 2 months ago |
Repare Therapeutics IncRPTX | 11 | Buy | $10.00 | +203.03% | Reiterates | 2 months ago |
Pmv Pharmaceuticals IncPMVP | 7 | Buy | $5.00 | +195.86% | Reiterates | 2 months ago |
Springworks Therapeutics IncSWTX | 20 | Buy | $74.00 | +70.59% | Maintains | 2 months ago |
Prelude Therapeutics IncPRLD | 8 | Hold | $5.00 | +29.20% | Downgrades | 2 months ago |
Nurix Therapeutics IncNRIX | 10 | Buy | $19.00 | +38.18% | Maintains | 2 months ago |
Y Mabs Therapeutics IncYMAB | 8 | Buy | $21.00 | +37.34% | Maintains | 2 months ago |
Kineta IncKA | 4 | Buy | $8.00 | +1,190.32% | Reiterates | 3 months ago |
Elicio Therapeutics IncELTX | 2 | Buy | $11.00 | +18.92% | Maintains | 3 months ago |
Kronos Bio IncKRON | 7 | Buy | $2.50 | +160.42% | Maintains | 4 months ago |
Cogent Biosciences IncCOGT | 4 | Buy | $13.00 | +98.78% | Maintains | 4 months ago |
Relay Therapeutics IncRLAY | 12 | Buy | $17.00 | +167.72% | Maintains | 4 months ago |
Portage Biotech IncPRTG | 5 | Buy | $6.00 | +2,300.00% | Maintains | 5 months ago |
Aadi Bioscience IncAADI | 9 | Buy | $36.00 | +1,922.47% | Maintains | 5 months ago |
Replimune Group IncREPL | 8 | Buy | $48.00 | +658.29% | Maintains | 5 months ago |
Omega Therapeutics IncOMGA | 6 | Buy | $12.00 | +415.02% | Maintains | 5 months ago |
Exelixis IncEXEL | 1 | Buy | $28.00 | +18.09% | Initiates Coverage On | 7 months ago |
Kinnate Biopharma IncKNTE | 6 | Buy | $24.00 | +805.66% | Reiterates | 8 months ago |
Gt Biopharma IncGTBP | 6 | Buy | $150.00 | +4,009.59% | Reiterates | 9 months ago |
Atara Biotherapeutics IncATRA | 5 | Buy | $28.00 | +3,816.08% | Maintains | 10 months ago |
Ikena Oncology IncIKNA | 4 | Buy | $22.00 | N/A | Reiterates | a year ago |
Fate Therapeutics IncFATE | 6 | Hold | $7.00 | N/A | Downgrades | a year ago |
Tcr2 Therapeutics IncTCRR | 4 | Buy | $13.00 | N/A | Maintains | a year ago |
Neurogene IncNGNE | 3 | Hold | N/A | N/A | Downgrades | a year ago |
Forma Therapeutics Holdings IncFMTX | 2 | Hold | $20.00 | N/A | Downgrades | 2 years ago |
Turning Point Therapeutics IncTPTX | 6 | Hold | $76.00 | N/A | Downgrades | 2 years ago |
Cytomx Therapeutics IncCTMX | 1 | Buy | $11.00 | N/A | Maintains | 2 years ago |
Nucana PLCNCNA | 7 | Buy | $225.00 | N/A | Maintains | 2 years ago |
Molecular Partners AgMOLN | 1 | Buy | $25.00 | N/A | Assumes | 3 years ago |
Autolus Therapeutics PLCAUTL | 1 | Buy | $13.00 | N/A | Maintains | 3 years ago |
Immunomedics IncIMMU | 4 | Hold | $88.00 | N/A | Downgrades | 4 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.